7 hasil untuk "Franceschini L"
Menampilkan 1–7 · 0,49 detik · RSS
-
Artikel Jurnal Teks lengkap
Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis
Objective: To analyse the relation between restrictive mitral pattern, amino-terminal propeptide of type III procollagen (PIIINP), and prognosis in patients with dilated cardiomyopathy. Design: Prospective cohort study of 106 patients with dilated cardiomyopathy. Setting: Tertiary care centre. Main…
-
Artikel Jurnal Teks lengkap
Gain of 20q11.21 in Human Pluripotent Stem Cells Impairs TGF-β-Dependent Neuroectodermal Commitment
Gain of 20q11.21 is one of the most common recurrent genomic aberrations in human pluripotent stem cells. Although it is known that overexpression of the antiapoptotic gene Bcl-xL confers a survival advantage to the abnormal cells, their differentiation capacity has not been fully investigated. RNA…
-
Artikel Jurnal Teks lengkap
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
INTRODUCTION: Bone involvement in Multiple Myeloma results from increased osteoclast formation and activity that occurs in proximity to myeloma cells. The role of Alkaline Phosphatse (ALP) in this process and the diagnostic significance of plasma levels in patients with MM are unclear. AIM: To…
-
Artikel Jurnal
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy
Valentina Perrone,1 Gregorio Barilà,2 Luca Franceschini,3 Giuseppe Mele,4 Stefania Mazzoni,1 Maria Cappuccilli,1 Margherita Andretta,5 Marcello Bacca,6 Fausto Bartolini,7 Antonietta Barbieri,8 Alessandra Blasi,9 Alessandro Chinellato,10 Stefania Dell’Orco,11 Fulvio Ferrante,12 Renato Lombardi,13…
-
Artikel Jurnal Teks lengkap
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
The treatment landscape of multiple myeloma (MM) has been revolutionized over the past two decades, leading to unprecedented deep and durable responses, prolonged survival, and improved quality of life. Nonetheless, MM is still an incurable disease, and many patients, especially those with…
-
Artikel Jurnal Teks lengkap
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients
BACKGROUND: Daratumumab-refractory multiple myeloma (Dara-R MM) presents a significant treatment challenge. This study aimed to evaluate the efficacy and survival outcomes of elotuzumab, pomalidomide, and dexamethasone (EloPd) in a large, real-world cohort of patients with Dara-R MM, with…